Nanotherapeutics for multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanotherapeutics for multiple myeloma

Published:2018-04-26 Issue:6 Volume:10 Page:
ISSN:1939-5116
Container-title:WIREs Nanomedicine and Nanobiotechnology
language:en
Short-container-title:WIREs Nanomed Nanobiotechnol

Author:

Zheleznyak Alexander¹,Shokeen Monica¹²,Achilefu Samuel¹²³⁴^ORCID

Affiliation:

1. Department of RadiologyWashington UniversitySt. LouisMissouri

2. Department of Biomedical EngineeringWashington UniversitySt. LouisMissouri

3. Department of Biochemistry and Molecular BiophysicsWashington UniversitySt. LouisMissouri

4. Department of MedicineWashington UniversitySt. LouisMissouri

Funder

National Institutes of Health

Publisher

Wiley

Subject

Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/wnan.1526

Reference111 articles.

1. WITHDRAWN: Treatment of cancer by low intensity laser radiation therapy

2. Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer

3. A Phase I Single-Agent Study of Twice-Weekly Consecutive-Day Dosing of the Proteasome Inhibitor Carfilzomib in Patients with Relapsed or Refractory Multiple Myeloma or Lymphoma

4. Regulation of hematopoietic stem cells by bone marrow stromal cells

5. Dual Carfilzomib and Doxorubicin–Loaded Liposomal Nanoparticles for Synergistic Efficacy in Multiple Myeloma

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advancements in nanomedicine as a revolutionary approach to treating multiple myeloma;Life Sciences;2024-11

2. Advancements in drugs restructured with nanomedicines for multiple myeloma treatment;Science China Materials;2024-09-10

3. Targeted Delivery Strategies for Multiple Myeloma and Their Adverse Drug Reactions;Pharmaceuticals;2024-06-25

4. Review on Bortezomib Resistance in Multiple Myeloma and Potential Role of Emerging Technologies;Pharmaceuticals;2023-01-12

5. Nanotechnology for diagnosis and treatment of dental and orthopedic diseases;Emerging Nanotechnologies for Medical Applications;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3